@akashpatel121 Profile picture

Akash Patel

@akashpatel121

#Biotech #Pharma #LifeSciences | Pharma Analyst @Pharma_GD | @science_eclub | @NASSexercise #AS #axSpA

Similar User
Rod photo

@rod_mallo

Innovation Forum photo

@Innovation_F

Steven O Connell 🇮🇪🇪🇺 photo

@thelovelysteve

LazioInnova photo

@LazioInnova

British Biosimilars photo

@BritBiosimilars

Howard Partridge 🍐 photo

@HowardPeartree

Aurora Pro Scientific- Make Fluidics Easy photo

@AuroaPro

Soraya Jones photo

@SorayaJones12

brokesanee photo

@japdongsanee

Akash Patel Reposted

🧵 Here are 10 amazing things that happened this year in #biotech.🧬


Akash Patel Reposted

Going back to normal is not enough. A revamp is required. nature.com/articles/d4158…


Akash Patel Reposted

“The pricing of insulin pens has skyrocketed over the past several years in the US, and affordability may hammer device penetration during the Covid-19 crisis," said Tina Deng, principal medical devices analyst at GlobalData. nsmedicaldevices.com/news/insulin-p…


Akash Patel Reposted

Today is #WorldArthritisDay and the start of #BoneJointWeek. MSK health is more important than ever. Help us to achieve #AccessForAS @NASSexercise @NASS_ASone bit.ly/36RteLE


Akash Patel Reposted

Biocon and Voluntis deal aims to personalize treatment for type 2 #diabetic patients on #insulin - bit.ly/33gQhNU


Akash Patel Reposted

Biocon and Voluntis deal aims to personalize treatment for type 2 #diabetic patients on #insulin - bit.ly/33gQhNU


Akash Patel Reposted

Label update to encourage prescription of anti-diabetic drugs outside the SGLT-2 inhibitor class - bit.ly/2WPpqVz


Akash Patel Reposted

OUR NEW PAPER. Factors associated with COVID-19-related hospital death in the linked electronic health records of 17 MILLION adult NHS patients. Largest study of its kind ever, anywhere. The power of UK / NHS data, realised. opensafely.org/outputs/2020/0… medrxiv.org/cgi/content/sh…


Akash Patel Reposted

Increased demand for cardiovascular drugs to exacerbate the disruption caused by COVID-19 - bit.ly/2VYko92


Akash Patel Reposted

Dapnat launch to boost Natco’s presence in India’s diabetes market but concerted efforts required, says #GlobalData bit.ly/2VMoYHv #astrazeneca #Dapagliflozin #Dapnat #Diabetes #Forxiga #India #Natco @JesseC_GD


Akash Patel Reposted

Happy to share our huge collaborative effort @UCBerkeley @UCSF to systematically evaluate coronavirus antibody tests. We'll be updating with new data at covidtestingproject.org - 10 lateral flow assays and 2 ELISAs so far. Read more @nytimes: nytimes.com/2020/04/24/hea…


Akash Patel Reposted

COVID-19 pandemic interferes with treatments in female health space - bit.ly/2RLffP5 #femalehealth #COVID19


Akash Patel Reposted

Recently completed #COVID19 #clinicaltrials show mixed results, says GlobalData globaldata.com/recently-compl…


Akash Patel Reposted

You might have seen a “scientific study” that said chloroquine can cure #COVID19…and then another one that shows that it can’t. Wondering what’s up with this? Are scientists lying to us? Are they just confused? Usually not. It all has to do with how we do science. A thread.


Akash Patel Reposted

The SEC #team wishes everyone a very Happy Easter 🐣🐰🌷🌞🥚! Amidst the current situation, we hope you #staypositive, #connect with your family and friends and #keepgoing! #motivation #stayhome #happyeaster #easterweekend

Tweet Image 1

"What is viral load and why are so many health workers getting sick?" twitter.com/i/events/12449…


Akash Patel Reposted

Single-cell RNA-seq & Cell Atlas projects have promised to impact almost every aspect of biology and medicine. Now is the time for the community to live up to this promise! Here's a summary of >10 COVID-19/SARS-CoV-2 single-cell data/studies. Please retweet & reuse data. (1/n)


Akash Patel Reposted

Est 330m people, 15% of the 9MM population, face risk of severe COVID-19, says GlobalData Epidemiologists, read Katie Wrenn Associate Epidemiologist at GlobalData views on the current challenges facing the 9MM bit.ly/2UnxgEY


Loading...

Something went wrong.


Something went wrong.